Same industry

NTLA against four same-industry peers, a year at 100

100150200250Feb ’26MayAugNov ’26IDXX−6.8%LNTH+82.9%NEOG+84.4%CLDX+5.8%NTLA+21.8%

NTLA +21.8%. Neogen +84.4%, Lantheus Holdings +82.9%, Celldex Therapeutics +5.8%, Idexx Laboratories −6.8%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in NTLA’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

NTLA: stories, the record and filings →